Follow the Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. - H Shs stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Market capitalisation: €6.2bn. The latest transaction was disclosed on 24 June 2026 (Other). Among the most active insiders: FU HANG. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a company focused on the development and production of biopharmaceutical products based on genetics. It emphasizes innovation in the field of biological therapies and genetic medicines.